Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renew Dialysis was a U.S. regional provider of on-site dialysis services delivered in skilled nursing facilities. The company focused on bringing hemodialysis care directly to patients in long-term care settings, allowing treatment within the facility rather than requiring transport to external dialysis centers. Renew Dialysis operated primarily in Ohio, with additional presence in Virginia, and was co-founded with involvement from Saber Healthcare Group and Nola McMullen. In January 2022, the business was acquired by Dialyze Direct, which integrated Renew Dialysis into its broader skilled-nursing-facility dialysis platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renew Dialysis.